Your browser doesn't support javascript.
loading
MEX3C-Mediated Decay of SOCS3 mRNA Promotes JAK2/STAT3 Signaling to Facilitate Metastasis in Hepatocellular Carcinoma.
Xiao, Yunyun; Li, Yue; Shi, Dongni; Wang, Xiaoqing; Dai, Shuqin; Yang, Muwen; Kong, Lingzhi; Chen, Boyu; Huang, Xinjian; Lin, Chuyong; Liao, Wenting; Xu, Benke; Chen, Xin; Wang, Lishuai; Chen, Xiangfu; Ouyang, Ying; Liu, Guozhen; Li, Heping; Song, Libing.
Affiliation
  • Xiao Y; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Li Y; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Shi D; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Wang X; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Dai S; Department of Medicinal Laboratory, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Yang M; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Kong L; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Chen B; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Huang X; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Lin C; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Liao W; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Xu B; Department of Human Anatomy, School of Basic Medical Sciences, Yangtze University, Jingzhou, China.
  • Chen X; Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences; Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China.
  • Wang L; Department of Medical Oncology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Chen X; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Ouyang Y; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Liu G; School of Medicine, The Chinese University of Hong Kong, Shenzhen, China.
  • Li H; Department of Medical Oncology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Song L; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Cancer Res ; 82(22): 4191-4205, 2022 11 15.
Article in En | MEDLINE | ID: mdl-36112698
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: RNA-Binding Proteins / Carcinoma, Hepatocellular / RNA Stability / STAT3 Transcription Factor / Janus Kinase 2 / Suppressor of Cytokine Signaling 3 Protein / Liver Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Cancer Res Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: RNA-Binding Proteins / Carcinoma, Hepatocellular / RNA Stability / STAT3 Transcription Factor / Janus Kinase 2 / Suppressor of Cytokine Signaling 3 Protein / Liver Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Cancer Res Year: 2022 Document type: Article